Dysregulated Treg repair responses lead to chronic rejection after heart transplantation

Chronic rejection (CR) after organ transplantation is alloimmune injury manifested by graft vascular remodeling and fibrosis that is resistant to immunosuppression. Single-cell RNA-Seq analysis of MHC class II-mismatched (MHCII-mismatched) heart transplants developing chronic rejection identified graft IL-33 as a stimulator of tissue repair pathways in infiltrating macrophages and Tregs. Using IL-33-deficient donor mice, we show that graft fibroblast-derived IL-33 potently induced amphiregulin (Areg) expression by recipient Tregs. The assessment of clinical samples also confirmed increased expression of Areg by intragraft Tregs also during rejection. Areg is an EGF secreted by multiple immune cells to shape immunomodulation and tissue repair. In particular, Areg is proposed to play a major role in Treg-mediated muscle, epithelium, and nerve repair. Assessment of recipient mice with Treg-specific deletion of Areg surprisingly uncovered that Treg secretion of Areg contributed to CR. Specifically, heart transplants from recipients with Areg-deficient Tregs showed less fibrosis, vasculopathy, and vessel-associated fibrotic niches populated by recipient T cells. Mechanistically, we show that Treg-secreted Areg functioned to increase fibroblast proliferation. In total, these studies identify how a dysregulated repair response involving interactions between IL-33+ fibroblasts in the allograft and recipient Tregs contributed to the progression of CR.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Investigation
Published
2024-12-01
DOI
https://doi.org/10.1172/jci173593
Citations
8
Primary Topic
Transplantation: Methods and Outcomes
Type
article
Field-Weighted Citation Impact
4.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dysregulated Treg repair responses lead to chronic rejection after heart transplantation

Tracy Tabib, Michelle A. Wood, Johnny Bou Saba, Andrew Lesniak et al.
8 citations
Journal of Clinical Investigation
Transplantation: Methods and Outcomes
4.58
article

Dysregulated Treg repair responses lead to chronic rejection after heart transplantation

Tracy Tabib, Michelle A. Wood, Johnny Bou Saba, Andrew Lesniak, Tengfang Li, Steven M. Sanders, Lu Fan, Sihua Wang, Khodor I. Abou‐Daya, Robert Lafyatis, Emmanuel León Colón, Lisa Mathews, Steven A. Webber, Gaelen K. Dwyer, Jordan Warunek, Kassandra J. Baron, H. Trent Spencer, Hēth Turnquist, Simon C. Watkins, Xue Zhang, Mark A. Ross, Anthony J. Demetris, Stephanie Traczek
article en
8 citations

Abstract

Chronic rejection (CR) after organ transplantation is alloimmune injury manifested by graft vascular remodeling and fibrosis that is resistant to immunosuppression. Single-cell RNA-Seq analysis of MHC class II-mismatched (MHCII-mismatched) heart transplants developing chronic rejection identified graft IL-33 as a stimulator of tissue repair pathways in infiltrating macrophages and Tregs. Using IL-33-deficient donor mice, we show that graft fibroblast-derived IL-33 potently induced amphiregulin (Areg) expression by recipient Tregs. The assessment of clinical samples also confirmed increased expression of Areg by intragraft Tregs also during rejection. Areg is an EGF secreted by multiple immune cells to shape immunomodulation and tissue repair. In particular, Areg is proposed to play a major role in Treg-mediated muscle, epithelium, and nerve repair. Assessment of recipient mice with Treg-specific deletion of Areg surprisingly uncovered that Treg secretion of Areg contributed to CR. Specifically, heart transplants from recipients with Areg-deficient Tregs showed less fibrosis, vasculopathy, and vessel-associated fibrotic niches populated by recipient T cells. Mechanistically, we show that Treg-secreted Areg functioned to increase fibroblast proliferation. In total, these studies identify how a dysregulated repair response involving interactions between IL-33+ fibroblasts in the allograft and recipient Tregs contributed to the progression of CR.

Journal of Clinical InvestigationVol. 134(23)
Union Hospital (HK), Central South University (CN), University of Pittsburgh (US), Second Xiangya Hospital of Central South University (CN), McGowan Institute for Regenerative Medicine (US), Huazhong University of Science and Technology (CN), University of Arkansas for Medical Sciences (US), Tsinghua University (CN)
American Society of Transplantation, National Institutes of Health
Openalex Percentile: Top 5%
Transplantation: Methods and Outcomes
4.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.